Cite

HARVARD Citation

    de, A. et al. (n.d.). Long‐term efficacy and safety of alemtuzumab in advanced primary cutaneous T‐cell lymphomas. British journal of dermatology. pp. 720-724. [Online]. 
  
Back to record